nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinblastine—head and neck cancer—skin cancer	0.293	0.594	CtDrD
Vinblastine—germ cell cancer—skin cancer	0.201	0.406	CtDrD
Vinblastine—ABCC6—Dactinomycin—skin cancer	0.0495	0.125	CbGbCtD
Vinblastine—TUBB4A—Docetaxel—skin cancer	0.0306	0.0771	CbGbCtD
Vinblastine—TUBB2B—Docetaxel—skin cancer	0.0306	0.0771	CbGbCtD
Vinblastine—TUBB3—Docetaxel—skin cancer	0.0306	0.0771	CbGbCtD
Vinblastine—TUBB2A—Docetaxel—skin cancer	0.0306	0.0771	CbGbCtD
Vinblastine—TUBB6—Docetaxel—skin cancer	0.0306	0.0771	CbGbCtD
Vinblastine—TUBB8—Docetaxel—skin cancer	0.0306	0.0771	CbGbCtD
Vinblastine—TUBB—Docetaxel—skin cancer	0.0256	0.0645	CbGbCtD
Vinblastine—TUBB1—Docetaxel—skin cancer	0.0256	0.0645	CbGbCtD
Vinblastine—TUBB4B—Docetaxel—skin cancer	0.0256	0.0645	CbGbCtD
Vinblastine—ABCC1—Vemurafenib—skin cancer	0.022	0.0555	CbGbCtD
Vinblastine—ABCC1—Dactinomycin—skin cancer	0.0146	0.0369	CbGbCtD
Vinblastine—ABCC1—Docetaxel—skin cancer	0.00754	0.019	CbGbCtD
Vinblastine—ABCB1—Vismodegib—skin cancer	0.00671	0.0169	CbGbCtD
Vinblastine—CYP3A4—Imiquimod—skin cancer	0.0058	0.0146	CbGbCtD
Vinblastine—CYP3A4—Temozolomide—skin cancer	0.0058	0.0146	CbGbCtD
Vinblastine—ABCC2—Docetaxel—skin cancer	0.00558	0.0141	CbGbCtD
Vinblastine—CYP2D6—Vemurafenib—skin cancer	0.005	0.0126	CbGbCtD
Vinblastine—CYP3A4—Vismodegib—skin cancer	0.00402	0.0101	CbGbCtD
Vinblastine—ABCB1—Dactinomycin—skin cancer	0.00352	0.0089	CbGbCtD
Vinblastine—ABCC6—dermis—skin cancer	0.00346	0.0759	CbGeAlD
Vinblastine—CYP3A4—Vemurafenib—skin cancer	0.00318	0.00802	CbGbCtD
Vinblastine—ABCB1—Docetaxel—skin cancer	0.00182	0.00459	CbGbCtD
Vinblastine—Ischaemia—Imiquimod—skin cancer	0.00182	0.0385	CcSEcCtD
Vinblastine—TUBD1—nipple—skin cancer	0.00122	0.0269	CbGeAlD
Vinblastine—JUN—skin epidermis—skin cancer	0.00122	0.0268	CbGeAlD
Vinblastine—TUBE1—nipple—skin cancer	0.00115	0.0252	CbGeAlD
Vinblastine—CYP3A4—Docetaxel—skin cancer	0.00109	0.00275	CbGbCtD
Vinblastine—TUBA1A—nerve—skin cancer	0.00105	0.023	CbGeAlD
Vinblastine—JUN—nerve—skin cancer	0.00104	0.0228	CbGeAlD
Vinblastine—TUBG1—nipple—skin cancer	0.00103	0.0226	CbGeAlD
Vinblastine—Myelosuppression—Bleomycin—skin cancer	0.001	0.0213	CcSEcCtD
Vinblastine—Myelosuppression—Dactinomycin—skin cancer	0.000937	0.0198	CcSEcCtD
Vinblastine—TUBA1A—Sorafenib—Vismodegib—skin cancer	0.000925	0.463	CbGdCrCtD
Vinblastine—JUN—endothelium—skin cancer	0.000884	0.0194	CbGeAlD
Vinblastine—TUBA1A—hair follicle—skin cancer	0.000878	0.0193	CbGeAlD
Vinblastine—Myelosuppression—Temozolomide—skin cancer	0.000847	0.0179	CcSEcCtD
Vinblastine—TUBB4B—skin epidermis—skin cancer	0.00082	0.018	CbGeAlD
Vinblastine—JUN—blood vessel—skin cancer	0.000815	0.0179	CbGeAlD
Vinblastine—Myelosuppression—Fluorouracil—skin cancer	0.00078	0.0165	CcSEcCtD
Vinblastine—TUBD1—mammalian vulva—skin cancer	0.000715	0.0157	CbGeAlD
Vinblastine—TUBB4B—Sorafenib—Vismodegib—skin cancer	0.000715	0.358	CbGdCrCtD
Vinblastine—Neoplasm—Vemurafenib—skin cancer	0.000703	0.0149	CcSEcCtD
Vinblastine—Bone pain—Imiquimod—skin cancer	0.000692	0.0146	CcSEcCtD
Vinblastine—TUBB—hair follicle—skin cancer	0.000686	0.0151	CbGeAlD
Vinblastine—TUBE1—mammalian vulva—skin cancer	0.000671	0.0147	CbGeAlD
Vinblastine—TUBG1—skin of body—skin cancer	0.000658	0.0145	CbGeAlD
Vinblastine—TUBD1—female reproductive system—skin cancer	0.000613	0.0135	CbGeAlD
Vinblastine—TUBG1—mammalian vulva—skin cancer	0.0006	0.0132	CbGeAlD
Vinblastine—TUBA1A—nipple—skin cancer	0.000595	0.0131	CbGeAlD
Vinblastine—TUBB3—connective tissue—skin cancer	0.000593	0.013	CbGeAlD
Vinblastine—JUN—nipple—skin cancer	0.000589	0.0129	CbGeAlD
Vinblastine—TUBA1A—neck—skin cancer	0.000589	0.0129	CbGeAlD
Vinblastine—TUBB4B—hair follicle—skin cancer	0.000585	0.0129	CbGeAlD
Vinblastine—JUN—neck—skin cancer	0.000583	0.0128	CbGeAlD
Vinblastine—TUBE1—female reproductive system—skin cancer	0.000574	0.0126	CbGeAlD
Vinblastine—Myelosuppression—Docetaxel—skin cancer	0.000563	0.0119	CcSEcCtD
Vinblastine—Alopecia—Vismodegib—skin cancer	0.000558	0.0118	CcSEcCtD
Vinblastine—Extravasation—Bleomycin—skin cancer	0.00054	0.0114	CcSEcCtD
Vinblastine—NR5A1—lymphoid tissue—skin cancer	0.00052	0.0114	CbGeAlD
Vinblastine—TUBG1—female reproductive system—skin cancer	0.000514	0.0113	CbGeAlD
Vinblastine—Nystagmus—Fluorouracil—skin cancer	0.000512	0.0108	CcSEcCtD
Vinblastine—TUBB8—head—skin cancer	0.000512	0.0112	CbGeAlD
Vinblastine—TUBD1—head—skin cancer	0.000512	0.0112	CbGeAlD
Vinblastine—Extravasation—Dactinomycin—skin cancer	0.000503	0.0107	CcSEcCtD
Vinblastine—NR5A1—female reproductive system—skin cancer	0.000501	0.011	CbGeAlD
Vinblastine—ABCC6—connective tissue—skin cancer	0.000499	0.011	CbGeAlD
Vinblastine—TUBB2B—nipple—skin cancer	0.000492	0.0108	CbGeAlD
Vinblastine—Cerebrovascular accident—Imiquimod—skin cancer	0.000491	0.0104	CcSEcCtD
Vinblastine—TUBE1—head—skin cancer	0.00048	0.0105	CbGeAlD
Vinblastine—TUBB—nipple—skin cancer	0.000465	0.0102	CbGeAlD
Vinblastine—TUBB2A—nipple—skin cancer	0.000463	0.0102	CbGeAlD
Vinblastine—TUBB6—nipple—skin cancer	0.000456	0.01	CbGeAlD
Vinblastine—Numbness—Fluorouracil—skin cancer	0.000441	0.00935	CcSEcCtD
Vinblastine—TUBB3—lymphoid tissue—skin cancer	0.000433	0.00952	CbGeAlD
Vinblastine—TUBG1—head—skin cancer	0.000429	0.00943	CbGeAlD
Vinblastine—Neuropathy peripheral—Vemurafenib—skin cancer	0.000426	0.00902	CcSEcCtD
Vinblastine—Sensory loss—Fluorouracil—skin cancer	0.000422	0.00894	CcSEcCtD
Vinblastine—TUBA1A—connective tissue—skin cancer	0.000422	0.00927	CbGeAlD
Vinblastine—Extravasation—Fluorouracil—skin cancer	0.000419	0.00888	CcSEcCtD
Vinblastine—NR5A1—head—skin cancer	0.000419	0.0092	CbGeAlD
Vinblastine—JUN—connective tissue—skin cancer	0.000418	0.00918	CbGeAlD
Vinblastine—ABCC1—hair follicle—skin cancer	0.000417	0.00916	CbGeAlD
Vinblastine—Cellulitis—Fluorouracil—skin cancer	0.000402	0.00852	CcSEcCtD
Vinblastine—TUBA1A—epithelium—skin cancer	0.000401	0.0088	CbGeAlD
Vinblastine—JUN—epithelium—skin cancer	0.000397	0.00872	CbGeAlD
Vinblastine—Phlebitis—Bleomycin—skin cancer	0.000397	0.0084	CcSEcCtD
Vinblastine—TUBB4B—nipple—skin cancer	0.000397	0.00871	CbGeAlD
Vinblastine—Pancytopenia—Imiquimod—skin cancer	0.000395	0.00836	CcSEcCtD
Vinblastine—Decreased appetite—Vismodegib—skin cancer	0.00039	0.00826	CcSEcCtD
Vinblastine—Pain—Vismodegib—skin cancer	0.000384	0.00813	CcSEcCtD
Vinblastine—Constipation—Vismodegib—skin cancer	0.000384	0.00813	CcSEcCtD
Vinblastine—TUBA1A—skin of body—skin cancer	0.000381	0.00837	CbGeAlD
Vinblastine—JUN—skin of body—skin cancer	0.000377	0.00829	CbGeAlD
Vinblastine—Ileus—Docetaxel—skin cancer	0.000373	0.0079	CcSEcCtD
Vinblastine—Phlebitis—Dactinomycin—skin cancer	0.00037	0.00783	CcSEcCtD
Vinblastine—Depression—Imiquimod—skin cancer	0.00037	0.00783	CcSEcCtD
Vinblastine—Gastrointestinal pain—Vismodegib—skin cancer	0.000367	0.00777	CcSEcCtD
Vinblastine—Acute coronary syndrome—Imiquimod—skin cancer	0.000365	0.00774	CcSEcCtD
Vinblastine—Myocardial infarction—Imiquimod—skin cancer	0.000363	0.00769	CcSEcCtD
Vinblastine—Neuropathy peripheral—Imiquimod—skin cancer	0.000363	0.00769	CcSEcCtD
Vinblastine—TUBB4A—connective tissue—skin cancer	0.000361	0.00792	CbGeAlD
Vinblastine—Neoplasm—Temozolomide—skin cancer	0.000359	0.0076	CcSEcCtD
Vinblastine—TUBD1—lymph node—skin cancer	0.000358	0.00787	CbGeAlD
Vinblastine—TUBB6—Sorafenib—Vismodegib—skin cancer	0.000356	0.178	CbGdCrCtD
Vinblastine—Abdominal pain—Vismodegib—skin cancer	0.000355	0.00751	CcSEcCtD
Vinblastine—Neuritis—Docetaxel—skin cancer	0.000354	0.00749	CcSEcCtD
Vinblastine—TUBB3—head—skin cancer	0.000349	0.00767	CbGeAlD
Vinblastine—Cerebrovascular accident—Bleomycin—skin cancer	0.000349	0.00738	CcSEcCtD
Vinblastine—TUBB2B—connective tissue—skin cancer	0.000349	0.00766	CbGeAlD
Vinblastine—TUBA1A—mammalian vulva—skin cancer	0.000348	0.00764	CbGeAlD
Vinblastine—Alopecia—Vemurafenib—skin cancer	0.000345	0.0073	CcSEcCtD
Vinblastine—JUN—mammalian vulva—skin cancer	0.000344	0.00756	CbGeAlD
Vinblastine—Photophobia—Fluorouracil—skin cancer	0.000344	0.00727	CcSEcCtD
Vinblastine—TUBB1—head—skin cancer	0.000341	0.0075	CbGeAlD
Vinblastine—TUBE1—lymph node—skin cancer	0.000336	0.00738	CbGeAlD
Vinblastine—Haemoglobin—Imiquimod—skin cancer	0.000335	0.00708	CcSEcCtD
Vinblastine—Haemorrhage—Imiquimod—skin cancer	0.000333	0.00705	CcSEcCtD
Vinblastine—Pharyngitis—Imiquimod—skin cancer	0.00033	0.00699	CcSEcCtD
Vinblastine—TUBB2A—connective tissue—skin cancer	0.000328	0.00721	CbGeAlD
Vinblastine—TUBB4A—skin of body—skin cancer	0.000326	0.00715	CbGeAlD
Vinblastine—Deafness—Temozolomide—skin cancer	0.000322	0.00682	CcSEcCtD
Vinblastine—Asthenia—Vismodegib—skin cancer	0.000322	0.00682	CcSEcCtD
Vinblastine—TUBA1A—lymphoid tissue—skin cancer	0.000309	0.00678	CbGeAlD
Vinblastine—TUBB6—epithelium—skin cancer	0.000307	0.00675	CbGeAlD
Vinblastine—Diarrhoea—Vismodegib—skin cancer	0.000307	0.0065	CcSEcCtD
Vinblastine—JUN—lymphoid tissue—skin cancer	0.000306	0.00671	CbGeAlD
Vinblastine—Extravasation—Docetaxel—skin cancer	0.000303	0.00641	CcSEcCtD
Vinblastine—TUBG1—lymph node—skin cancer	0.000301	0.00661	CbGeAlD
Vinblastine—TUBA1A—female reproductive system—skin cancer	0.000298	0.00654	CbGeAlD
Vinblastine—TUBB2A—skin of body—skin cancer	0.000296	0.00651	CbGeAlD
Vinblastine—JUN—female reproductive system—skin cancer	0.000295	0.00648	CbGeAlD
Vinblastine—Alopecia—Imiquimod—skin cancer	0.000294	0.00623	CcSEcCtD
Vinblastine—ABCC6—head—skin cancer	0.000294	0.00646	CbGeAlD
Vinblastine—TUBB6—skin of body—skin cancer	0.000292	0.00642	CbGeAlD
Vinblastine—TUBB2B—mammalian vulva—skin cancer	0.000287	0.00631	CbGeAlD
Vinblastine—Vomiting—Vismodegib—skin cancer	0.000285	0.00604	CcSEcCtD
Vinblastine—ABCC1—nipple—skin cancer	0.000283	0.00621	CbGeAlD
Vinblastine—TUBB4B—connective tissue—skin cancer	0.000281	0.00618	CbGeAlD
Vinblastine—Pancytopenia—Bleomycin—skin cancer	0.000281	0.00594	CcSEcCtD
Vinblastine—Bone pain—Docetaxel—skin cancer	0.000276	0.00584	CcSEcCtD
Vinblastine—TUBB—mammalian vulva—skin cancer	0.000272	0.00597	CbGeAlD
Vinblastine—TUBB2A—mammalian vulva—skin cancer	0.00027	0.00594	CbGeAlD
Vinblastine—Ill-defined disorder—Imiquimod—skin cancer	0.000269	0.00569	CcSEcCtD
Vinblastine—Nausea—Vismodegib—skin cancer	0.000267	0.00564	CcSEcCtD
Vinblastine—TUBB6—mammalian vulva—skin cancer	0.000267	0.00586	CbGeAlD
Vinblastine—TUBB4A—lymphoid tissue—skin cancer	0.000264	0.00579	CbGeAlD
Vinblastine—Pancytopenia—Dactinomycin—skin cancer	0.000262	0.00554	CcSEcCtD
Vinblastine—Malaise—Imiquimod—skin cancer	0.000261	0.00553	CcSEcCtD
Vinblastine—Acute coronary syndrome—Bleomycin—skin cancer	0.00026	0.0055	CcSEcCtD
Vinblastine—Myocardial infarction—Bleomycin—skin cancer	0.000258	0.00547	CcSEcCtD
Vinblastine—TUBB4A—female reproductive system—skin cancer	0.000254	0.00559	CbGeAlD
Vinblastine—TUBB4B—skin of body—skin cancer	0.000254	0.00558	CbGeAlD
Vinblastine—Convulsion—Imiquimod—skin cancer	0.000251	0.00531	CcSEcCtD
Vinblastine—Hypertension—Imiquimod—skin cancer	0.00025	0.0053	CcSEcCtD
Vinblastine—TUBA1A—head—skin cancer	0.000249	0.00546	CbGeAlD
Vinblastine—JUN—head—skin cancer	0.000246	0.00541	CbGeAlD
Vinblastine—TUBB2B—female reproductive system—skin cancer	0.000246	0.0054	CbGeAlD
Vinblastine—Discomfort—Imiquimod—skin cancer	0.000244	0.00516	CcSEcCtD
Vinblastine—Decreased appetite—Vemurafenib—skin cancer	0.000241	0.0051	CcSEcCtD
Vinblastine—Neoplasm—Docetaxel—skin cancer	0.000239	0.00506	CcSEcCtD
Vinblastine—Haemoglobin—Bleomycin—skin cancer	0.000238	0.00503	CcSEcCtD
Vinblastine—Constipation—Vemurafenib—skin cancer	0.000237	0.00502	CcSEcCtD
Vinblastine—Pancytopenia—Temozolomide—skin cancer	0.000237	0.00501	CcSEcCtD
Vinblastine—TUBB6—lymphoid tissue—skin cancer	0.000237	0.0052	CbGeAlD
Vinblastine—Haemorrhage—Bleomycin—skin cancer	0.000236	0.00501	CcSEcCtD
Vinblastine—Hypoaesthesia—Bleomycin—skin cancer	0.000235	0.00498	CcSEcCtD
Vinblastine—TUBB4B—mammalian vulva—skin cancer	0.000232	0.00509	CbGeAlD
Vinblastine—TUBB2A—female reproductive system—skin cancer	0.000231	0.00508	CbGeAlD
Vinblastine—Agranulocytosis—Dactinomycin—skin cancer	0.000229	0.00485	CcSEcCtD
Vinblastine—TUBB6—female reproductive system—skin cancer	0.000228	0.00501	CbGeAlD
Vinblastine—Anorexia—Imiquimod—skin cancer	0.000225	0.00477	CcSEcCtD
Vinblastine—Angina pectoris—Fluorouracil—skin cancer	0.000224	0.00473	CcSEcCtD
Vinblastine—Phlebitis—Docetaxel—skin cancer	0.000223	0.00471	CcSEcCtD
Vinblastine—Depression—Temozolomide—skin cancer	0.000222	0.00469	CcSEcCtD
Vinblastine—Pharyngitis—Dactinomycin—skin cancer	0.000219	0.00463	CcSEcCtD
Vinblastine—Pancytopenia—Fluorouracil—skin cancer	0.000218	0.00462	CcSEcCtD
Vinblastine—Neuropathy peripheral—Temozolomide—skin cancer	0.000218	0.00461	CcSEcCtD
Vinblastine—Deafness—Docetaxel—skin cancer	0.000214	0.00454	CcSEcCtD
Vinblastine—TUBB4A—head—skin cancer	0.000212	0.00467	CbGeAlD
Vinblastine—Paraesthesia—Imiquimod—skin cancer	0.000212	0.0045	CcSEcCtD
Vinblastine—Alopecia—Bleomycin—skin cancer	0.000209	0.00442	CcSEcCtD
Vinblastine—TUBB4B—lymphoid tissue—skin cancer	0.000206	0.00452	CbGeAlD
Vinblastine—Decreased appetite—Imiquimod—skin cancer	0.000206	0.00435	CcSEcCtD
Vinblastine—TUBB2B—head—skin cancer	0.000205	0.00451	CbGeAlD
Vinblastine—Hypersensitivity—Vemurafenib—skin cancer	0.000204	0.00432	CcSEcCtD
Vinblastine—Pain—Imiquimod—skin cancer	0.000202	0.00428	CcSEcCtD
Vinblastine—Acute coronary syndrome—Fluorouracil—skin cancer	0.000202	0.00427	CcSEcCtD
Vinblastine—Neuropathy peripheral—Fluorouracil—skin cancer	0.000201	0.00425	CcSEcCtD
Vinblastine—Myocardial infarction—Fluorouracil—skin cancer	0.000201	0.00425	CcSEcCtD
Vinblastine—Haemoglobin—Temozolomide—skin cancer	0.0002	0.00424	CcSEcCtD
Vinblastine—Haemorrhage—Temozolomide—skin cancer	0.000199	0.00422	CcSEcCtD
Vinblastine—Asthenia—Vemurafenib—skin cancer	0.000199	0.00421	CcSEcCtD
Vinblastine—Hypoaesthesia—Temozolomide—skin cancer	0.000198	0.0042	CcSEcCtD
Vinblastine—TUBB4B—female reproductive system—skin cancer	0.000198	0.00436	CbGeAlD
Vinblastine—Pharyngitis—Temozolomide—skin cancer	0.000198	0.00419	CcSEcCtD
Vinblastine—Alopecia—Dactinomycin—skin cancer	0.000195	0.00413	CcSEcCtD
Vinblastine—Feeling abnormal—Imiquimod—skin cancer	0.000195	0.00413	CcSEcCtD
Vinblastine—Gastrointestinal pain—Imiquimod—skin cancer	0.000193	0.00409	CcSEcCtD
Vinblastine—TUBB2A—head—skin cancer	0.000193	0.00425	CbGeAlD
Vinblastine—Agranulocytosis—Fluorouracil—skin cancer	0.000191	0.00404	CcSEcCtD
Vinblastine—Ill-defined disorder—Bleomycin—skin cancer	0.000191	0.00404	CcSEcCtD
Vinblastine—TUBB6—head—skin cancer	0.000191	0.00419	CbGeAlD
Vinblastine—Anaemia—Bleomycin—skin cancer	0.00019	0.00403	CcSEcCtD
Vinblastine—Diarrhoea—Vemurafenib—skin cancer	0.00019	0.00402	CcSEcCtD
Vinblastine—Abdominal pain—Imiquimod—skin cancer	0.000187	0.00396	CcSEcCtD
Vinblastine—Malaise—Bleomycin—skin cancer	0.000186	0.00393	CcSEcCtD
Vinblastine—Haemoglobin—Fluorouracil—skin cancer	0.000185	0.00391	CcSEcCtD
Vinblastine—Leukopenia—Bleomycin—skin cancer	0.000184	0.0039	CcSEcCtD
Vinblastine—Haemorrhage—Fluorouracil—skin cancer	0.000184	0.00389	CcSEcCtD
Vinblastine—Dizziness—Vemurafenib—skin cancer	0.000183	0.00388	CcSEcCtD
Vinblastine—Hypoaesthesia—Fluorouracil—skin cancer	0.000183	0.00387	CcSEcCtD
Vinblastine—Pharyngitis—Fluorouracil—skin cancer	0.000182	0.00386	CcSEcCtD
Vinblastine—Ill-defined disorder—Dactinomycin—skin cancer	0.000178	0.00377	CcSEcCtD
Vinblastine—Anaemia—Dactinomycin—skin cancer	0.000177	0.00376	CcSEcCtD
Vinblastine—Vomiting—Vemurafenib—skin cancer	0.000176	0.00373	CcSEcCtD
Vinblastine—Alopecia—Temozolomide—skin cancer	0.000176	0.00373	CcSEcCtD
Vinblastine—Hypersensitivity—Imiquimod—skin cancer	0.000174	0.00369	CcSEcCtD
Vinblastine—TUBA1A—lymph node—skin cancer	0.000174	0.00383	CbGeAlD
Vinblastine—Headache—Vemurafenib—skin cancer	0.000174	0.00368	CcSEcCtD
Vinblastine—Discomfort—Bleomycin—skin cancer	0.000173	0.00367	CcSEcCtD
Vinblastine—Malaise—Dactinomycin—skin cancer	0.000173	0.00366	CcSEcCtD
Vinblastine—JUN—lymph node—skin cancer	0.000172	0.00379	CbGeAlD
Vinblastine—Leukopenia—Dactinomycin—skin cancer	0.000172	0.00364	CcSEcCtD
Vinblastine—Asthenia—Imiquimod—skin cancer	0.00017	0.00359	CcSEcCtD
Vinblastine—TUBB4B—head—skin cancer	0.000166	0.00364	CbGeAlD
Vinblastine—ABCC1—mammalian vulva—skin cancer	0.000165	0.00363	CbGeAlD
Vinblastine—Nausea—Vemurafenib—skin cancer	0.000165	0.00349	CcSEcCtD
Vinblastine—Thrombocytopenia—Bleomycin—skin cancer	0.000164	0.00348	CcSEcCtD
Vinblastine—Alopecia—Fluorouracil—skin cancer	0.000162	0.00344	CcSEcCtD
Vinblastine—Diarrhoea—Imiquimod—skin cancer	0.000162	0.00343	CcSEcCtD
Vinblastine—Discomfort—Dactinomycin—skin cancer	0.000161	0.00342	CcSEcCtD
Vinblastine—Angina pectoris—Docetaxel—skin cancer	0.000161	0.00342	CcSEcCtD
Vinblastine—Ill-defined disorder—Temozolomide—skin cancer	0.000161	0.00341	CcSEcCtD
Vinblastine—Anaemia—Temozolomide—skin cancer	0.00016	0.0034	CcSEcCtD
Vinblastine—ABCC2—female reproductive system—skin cancer	0.00016	0.00353	CbGeAlD
Vinblastine—Anorexia—Bleomycin—skin cancer	0.00016	0.00339	CcSEcCtD
Vinblastine—ABCB1—blood vessel—skin cancer	0.00016	0.00351	CbGeAlD
Vinblastine—Pancytopenia—Docetaxel—skin cancer	0.000157	0.00333	CcSEcCtD
Vinblastine—Malaise—Temozolomide—skin cancer	0.000157	0.00331	CcSEcCtD
Vinblastine—Dizziness—Imiquimod—skin cancer	0.000156	0.00331	CcSEcCtD
Vinblastine—Vertigo—Temozolomide—skin cancer	0.000156	0.0033	CcSEcCtD
Vinblastine—Leukopenia—Temozolomide—skin cancer	0.000155	0.00329	CcSEcCtD
Vinblastine—Thrombocytopenia—Dactinomycin—skin cancer	0.000153	0.00325	CcSEcCtD
Vinblastine—Paraesthesia—Bleomycin—skin cancer	0.000151	0.00319	CcSEcCtD
Vinblastine—Convulsion—Temozolomide—skin cancer	0.00015	0.00318	CcSEcCtD
Vinblastine—Vomiting—Imiquimod—skin cancer	0.00015	0.00318	CcSEcCtD
Vinblastine—Hypertension—Temozolomide—skin cancer	0.00015	0.00317	CcSEcCtD
Vinblastine—Anorexia—Dactinomycin—skin cancer	0.000149	0.00316	CcSEcCtD
Vinblastine—TUBB4A—lymph node—skin cancer	0.000149	0.00327	CbGeAlD
Vinblastine—Headache—Imiquimod—skin cancer	0.000148	0.00314	CcSEcCtD
Vinblastine—Anaemia—Fluorouracil—skin cancer	0.000148	0.00313	CcSEcCtD
Vinblastine—Discomfort—Temozolomide—skin cancer	0.000146	0.00309	CcSEcCtD
Vinblastine—Decreased appetite—Bleomycin—skin cancer	0.000146	0.00309	CcSEcCtD
Vinblastine—Acute coronary syndrome—Docetaxel—skin cancer	0.000146	0.00308	CcSEcCtD
Vinblastine—Myocardial infarction—Docetaxel—skin cancer	0.000145	0.00307	CcSEcCtD
Vinblastine—Neuropathy peripheral—Docetaxel—skin cancer	0.000145	0.00307	CcSEcCtD
Vinblastine—TUBB2B—lymph node—skin cancer	0.000144	0.00316	CbGeAlD
Vinblastine—Pain—Bleomycin—skin cancer	0.000144	0.00304	CcSEcCtD
Vinblastine—Leukopenia—Fluorouracil—skin cancer	0.000143	0.00303	CcSEcCtD
Vinblastine—Nausea—Imiquimod—skin cancer	0.00014	0.00297	CcSEcCtD
Vinblastine—Thrombocytopenia—Temozolomide—skin cancer	0.000139	0.00294	CcSEcCtD
Vinblastine—Convulsion—Fluorouracil—skin cancer	0.000139	0.00293	CcSEcCtD
Vinblastine—Feeling abnormal—Bleomycin—skin cancer	0.000138	0.00293	CcSEcCtD
Vinblastine—Agranulocytosis—Docetaxel—skin cancer	0.000138	0.00292	CcSEcCtD
Vinblastine—Decreased appetite—Dactinomycin—skin cancer	0.000136	0.00288	CcSEcCtD
Vinblastine—TUBB—lymph node—skin cancer	0.000136	0.00299	CbGeAlD
Vinblastine—TUBB2A—lymph node—skin cancer	0.000135	0.00297	CbGeAlD
Vinblastine—Anorexia—Temozolomide—skin cancer	0.000135	0.00286	CcSEcCtD
Vinblastine—Discomfort—Fluorouracil—skin cancer	0.000135	0.00285	CcSEcCtD
Vinblastine—Pain—Dactinomycin—skin cancer	0.000134	0.00284	CcSEcCtD
Vinblastine—TUBB6—lymph node—skin cancer	0.000134	0.00293	CbGeAlD
Vinblastine—Haemoglobin—Docetaxel—skin cancer	0.000133	0.00282	CcSEcCtD
Vinblastine—Haemorrhage—Docetaxel—skin cancer	0.000133	0.00281	CcSEcCtD
Vinblastine—Hypoaesthesia—Docetaxel—skin cancer	0.000132	0.00279	CcSEcCtD
Vinblastine—Pharyngitis—Docetaxel—skin cancer	0.000132	0.00279	CcSEcCtD
Vinblastine—Feeling abnormal—Dactinomycin—skin cancer	0.000129	0.00273	CcSEcCtD
Vinblastine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000128	0.00271	CcSEcCtD
Vinblastine—Thrombocytopenia—Fluorouracil—skin cancer	0.000128	0.00271	CcSEcCtD
Vinblastine—Paraesthesia—Temozolomide—skin cancer	0.000127	0.00269	CcSEcCtD
Vinblastine—Anorexia—Fluorouracil—skin cancer	0.000124	0.00263	CcSEcCtD
Vinblastine—Abdominal pain—Dactinomycin—skin cancer	0.000124	0.00262	CcSEcCtD
Vinblastine—Hypersensitivity—Bleomycin—skin cancer	0.000124	0.00262	CcSEcCtD
Vinblastine—Decreased appetite—Temozolomide—skin cancer	0.000123	0.00261	CcSEcCtD
Vinblastine—Constipation—Temozolomide—skin cancer	0.000121	0.00257	CcSEcCtD
Vinblastine—Pain—Temozolomide—skin cancer	0.000121	0.00257	CcSEcCtD
Vinblastine—Asthenia—Bleomycin—skin cancer	0.000121	0.00255	CcSEcCtD
Vinblastine—Paraesthesia—Fluorouracil—skin cancer	0.000117	0.00248	CcSEcCtD
Vinblastine—Alopecia—Docetaxel—skin cancer	0.000117	0.00248	CcSEcCtD
Vinblastine—Feeling abnormal—Temozolomide—skin cancer	0.000117	0.00247	CcSEcCtD
Vinblastine—TUBB4B—lymph node—skin cancer	0.000116	0.00255	CbGeAlD
Vinblastine—Gastrointestinal pain—Temozolomide—skin cancer	0.000116	0.00245	CcSEcCtD
Vinblastine—Hypersensitivity—Dactinomycin—skin cancer	0.000115	0.00244	CcSEcCtD
Vinblastine—Decreased appetite—Fluorouracil—skin cancer	0.000114	0.0024	CcSEcCtD
Vinblastine—Asthenia—Dactinomycin—skin cancer	0.000112	0.00238	CcSEcCtD
Vinblastine—Abdominal pain—Temozolomide—skin cancer	0.000112	0.00237	CcSEcCtD
Vinblastine—Pain—Fluorouracil—skin cancer	0.000112	0.00236	CcSEcCtD
Vinblastine—Feeling abnormal—Fluorouracil—skin cancer	0.000108	0.00228	CcSEcCtD
Vinblastine—Diarrhoea—Dactinomycin—skin cancer	0.000107	0.00227	CcSEcCtD
Vinblastine—Vomiting—Bleomycin—skin cancer	0.000107	0.00226	CcSEcCtD
Vinblastine—Anaemia—Docetaxel—skin cancer	0.000107	0.00226	CcSEcCtD
Vinblastine—Hypersensitivity—Temozolomide—skin cancer	0.000104	0.00221	CcSEcCtD
Vinblastine—Leukopenia—Docetaxel—skin cancer	0.000103	0.00219	CcSEcCtD
Vinblastine—Asthenia—Temozolomide—skin cancer	0.000102	0.00215	CcSEcCtD
Vinblastine—Convulsion—Docetaxel—skin cancer	0.0001	0.00212	CcSEcCtD
Vinblastine—Nausea—Bleomycin—skin cancer	9.98e-05	0.00211	CcSEcCtD
Vinblastine—Hypertension—Docetaxel—skin cancer	9.97e-05	0.00211	CcSEcCtD
Vinblastine—Vomiting—Dactinomycin—skin cancer	9.96e-05	0.00211	CcSEcCtD
Vinblastine—Diarrhoea—Temozolomide—skin cancer	9.7e-05	0.00205	CcSEcCtD
Vinblastine—Hypersensitivity—Fluorouracil—skin cancer	9.62e-05	0.00204	CcSEcCtD
Vinblastine—ABCC2—lymph node—skin cancer	9.39e-05	0.00206	CbGeAlD
Vinblastine—Dizziness—Temozolomide—skin cancer	9.37e-05	0.00198	CcSEcCtD
Vinblastine—Nausea—Dactinomycin—skin cancer	9.31e-05	0.00197	CcSEcCtD
Vinblastine—Thrombocytopenia—Docetaxel—skin cancer	9.23e-05	0.00195	CcSEcCtD
Vinblastine—Vomiting—Temozolomide—skin cancer	9.01e-05	0.00191	CcSEcCtD
Vinblastine—Anorexia—Docetaxel—skin cancer	8.98e-05	0.0019	CcSEcCtD
Vinblastine—Diarrhoea—Fluorouracil—skin cancer	8.93e-05	0.00189	CcSEcCtD
Vinblastine—Headache—Temozolomide—skin cancer	8.88e-05	0.00188	CcSEcCtD
Vinblastine—Dizziness—Fluorouracil—skin cancer	8.63e-05	0.00183	CcSEcCtD
Vinblastine—Paraesthesia—Docetaxel—skin cancer	8.46e-05	0.00179	CcSEcCtD
Vinblastine—Nausea—Temozolomide—skin cancer	8.42e-05	0.00178	CcSEcCtD
Vinblastine—Vomiting—Fluorouracil—skin cancer	8.3e-05	0.00176	CcSEcCtD
Vinblastine—ABCC1—lymph node—skin cancer	8.27e-05	0.00182	CbGeAlD
Vinblastine—Decreased appetite—Docetaxel—skin cancer	8.19e-05	0.00173	CcSEcCtD
Vinblastine—Headache—Fluorouracil—skin cancer	8.18e-05	0.00173	CcSEcCtD
Vinblastine—CYP3A4—female reproductive system—skin cancer	8.15e-05	0.00179	CbGeAlD
Vinblastine—Constipation—Docetaxel—skin cancer	8.06e-05	0.00171	CcSEcCtD
Vinblastine—Pain—Docetaxel—skin cancer	8.06e-05	0.00171	CcSEcCtD
Vinblastine—CYP2D6—female reproductive system—skin cancer	8.02e-05	0.00176	CbGeAlD
Vinblastine—ABCB1—epithelium—skin cancer	7.77e-05	0.00171	CbGeAlD
Vinblastine—Feeling abnormal—Docetaxel—skin cancer	7.77e-05	0.00164	CcSEcCtD
Vinblastine—Nausea—Fluorouracil—skin cancer	7.76e-05	0.00164	CcSEcCtD
Vinblastine—Gastrointestinal pain—Docetaxel—skin cancer	7.71e-05	0.00163	CcSEcCtD
Vinblastine—Abdominal pain—Docetaxel—skin cancer	7.45e-05	0.00158	CcSEcCtD
Vinblastine—Hypersensitivity—Docetaxel—skin cancer	6.94e-05	0.00147	CcSEcCtD
Vinblastine—Asthenia—Docetaxel—skin cancer	6.76e-05	0.00143	CcSEcCtD
Vinblastine—ABCB1—mammalian vulva—skin cancer	6.74e-05	0.00148	CbGeAlD
Vinblastine—CYP2D6—head—skin cancer	6.7e-05	0.00147	CbGeAlD
Vinblastine—Diarrhoea—Docetaxel—skin cancer	6.45e-05	0.00137	CcSEcCtD
Vinblastine—Dizziness—Docetaxel—skin cancer	6.23e-05	0.00132	CcSEcCtD
Vinblastine—Vomiting—Docetaxel—skin cancer	5.99e-05	0.00127	CcSEcCtD
Vinblastine—ABCB1—lymphoid tissue—skin cancer	5.98e-05	0.00131	CbGeAlD
Vinblastine—Headache—Docetaxel—skin cancer	5.9e-05	0.00125	CcSEcCtD
Vinblastine—ABCB1—female reproductive system—skin cancer	5.77e-05	0.00127	CbGeAlD
Vinblastine—Nausea—Docetaxel—skin cancer	5.6e-05	0.00119	CcSEcCtD
Vinblastine—ABCB1—head—skin cancer	4.82e-05	0.00106	CbGeAlD
Vinblastine—JUN—B Cell Receptor Signaling Pathway—BRAF—skin cancer	3.93e-05	0.0027	CbGpPWpGaD
Vinblastine—JUN—TGF-beta Signaling Pathway—TERT—skin cancer	3.88e-05	0.00266	CbGpPWpGaD
Vinblastine—JUN—ATM Signaling Pathway—TP53—skin cancer	3.84e-05	0.00263	CbGpPWpGaD
Vinblastine—JUN—Apoptosis—CDKN2A—skin cancer	3.81e-05	0.00261	CbGpPWpGaD
Vinblastine—JUN—Oxidative Stress Induced Senescence—CDK4—skin cancer	3.77e-05	0.00259	CbGpPWpGaD
Vinblastine—TUBB—Cell Cycle—MLH1—skin cancer	3.75e-05	0.00258	CbGpPWpGaD
Vinblastine—JUN—PDGF Pathway—HRAS—skin cancer	3.74e-05	0.00257	CbGpPWpGaD
Vinblastine—JUN—Signaling events regulated by Ret tyrosine kinase—HRAS—skin cancer	3.74e-05	0.00257	CbGpPWpGaD
Vinblastine—JUN—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—skin cancer	3.74e-05	0.00257	CbGpPWpGaD
Vinblastine—JUN—Senescence and Autophagy in Cancer—BRAF—skin cancer	3.69e-05	0.00253	CbGpPWpGaD
Vinblastine—JUN—ErbB1 downstream signaling—BRAF—skin cancer	3.69e-05	0.00253	CbGpPWpGaD
Vinblastine—NR5A1—Developmental Biology—CDK4—skin cancer	3.68e-05	0.00253	CbGpPWpGaD
Vinblastine—TUBG1—Cell Cycle—CDKN2A—skin cancer	3.66e-05	0.00251	CbGpPWpGaD
Vinblastine—JUN—ErbB2/ErbB3 signaling events—HRAS—skin cancer	3.6e-05	0.00247	CbGpPWpGaD
Vinblastine—JUN—Apoptosis Modulation and Signaling—CDKN2A—skin cancer	3.57e-05	0.00245	CbGpPWpGaD
Vinblastine—JUN—IL-2 Signaling Pathway—HRAS—skin cancer	3.53e-05	0.00242	CbGpPWpGaD
Vinblastine—JUN—Pre-NOTCH Expression and Processing—TP53—skin cancer	3.49e-05	0.0024	CbGpPWpGaD
Vinblastine—JUN—FCERI mediated MAPK activation—HRAS—skin cancer	3.46e-05	0.00238	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—TLR7—skin cancer	3.46e-05	0.00238	CbGpPWpGaD
Vinblastine—JUN—IL2-mediated signaling events—KRAS—skin cancer	3.39e-05	0.00233	CbGpPWpGaD
Vinblastine—JUN—ErbB Signaling Pathway—KRAS—skin cancer	3.39e-05	0.00233	CbGpPWpGaD
Vinblastine—JUN—TWEAK Signaling Pathway—IL6—skin cancer	3.38e-05	0.00232	CbGpPWpGaD
Vinblastine—ABCB1—lymph node—skin cancer	3.38e-05	0.000742	CbGeAlD
Vinblastine—JUN—Downstream signaling in naïve CD8+ T cells—NRAS—skin cancer	3.36e-05	0.00231	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	3.33e-05	0.00229	CbGpPWpGaD
Vinblastine—JUN—FCERI mediated MAPK activation—IL6—skin cancer	3.31e-05	0.00228	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—RHOU—skin cancer	3.27e-05	0.00225	CbGpPWpGaD
Vinblastine—JUN—PDGFR-beta signaling pathway—BRAF—skin cancer	3.21e-05	0.0022	CbGpPWpGaD
Vinblastine—JUN—Senescence-Associated Secretory Phenotype (SASP)—CDKN2A—skin cancer	3.18e-05	0.00219	CbGpPWpGaD
Vinblastine—JUN—Senescence and Autophagy in Cancer—CDKN2A—skin cancer	3.18e-05	0.00219	CbGpPWpGaD
Vinblastine—JUN—IL-3 Signaling Pathway—HRAS—skin cancer	3.12e-05	0.00214	CbGpPWpGaD
Vinblastine—JUN—Integrated Breast Cancer Pathway—CDK4—skin cancer	3.12e-05	0.00214	CbGpPWpGaD
Vinblastine—JUN—Copper homeostasis—TP53—skin cancer	3.11e-05	0.00214	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle—MLH1—skin cancer	3.11e-05	0.00213	CbGpPWpGaD
Vinblastine—JUN—DNA Damage Response (only ATM dependent)—CDKN2A—skin cancer	3.09e-05	0.00212	CbGpPWpGaD
Vinblastine—JUN—IL6-mediated signaling events—IL6—skin cancer	3.09e-05	0.00212	CbGpPWpGaD
Vinblastine—ABCC2—Transmembrane transport of small molecules—SLC12A2—skin cancer	3.04e-05	0.00209	CbGpPWpGaD
Vinblastine—JUN—ErbB Signaling Pathway—TP53—skin cancer	3.02e-05	0.00207	CbGpPWpGaD
Vinblastine—ABCC1—Transmembrane transport of small molecules—SLC12A2—skin cancer	3e-05	0.00206	CbGpPWpGaD
Vinblastine—JUN—Downstream signaling in naïve CD8+ T cells—KRAS—skin cancer	2.89e-05	0.00199	CbGpPWpGaD
Vinblastine—JUN—ErbB Signaling Pathway—HRAS—skin cancer	2.89e-05	0.00198	CbGpPWpGaD
Vinblastine—JUN—TGF-beta Receptor Signaling—HRAS—skin cancer	2.89e-05	0.00198	CbGpPWpGaD
Vinblastine—JUN—IL2-mediated signaling events—HRAS—skin cancer	2.89e-05	0.00198	CbGpPWpGaD
Vinblastine—JUN—Oxidative Stress Induced Senescence—CDKN2A—skin cancer	2.88e-05	0.00198	CbGpPWpGaD
Vinblastine—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—skin cancer	2.86e-05	0.00196	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle—MLH1—skin cancer	2.84e-05	0.00195	CbGpPWpGaD
Vinblastine—JUN—Integrated Breast Cancer Pathway—BRAF—skin cancer	2.76e-05	0.00189	CbGpPWpGaD
Vinblastine—JUN—MAP kinase activation in TLR cascade—IL6—skin cancer	2.68e-05	0.00184	CbGpPWpGaD
Vinblastine—TUBA1A—Cell Cycle, Mitotic—CDK4—skin cancer	2.68e-05	0.00184	CbGpPWpGaD
Vinblastine—TUBA1A—Cell Cycle—TERT—skin cancer	2.67e-05	0.00184	CbGpPWpGaD
Vinblastine—ABCB1—HIF-1-alpha transcription factor network—TERT—skin cancer	2.65e-05	0.00182	CbGpPWpGaD
Vinblastine—JUN—Cellular Senescence—CDK4—skin cancer	2.64e-05	0.00181	CbGpPWpGaD
Vinblastine—JUN—Fc-epsilon receptor I signaling in mast cells—HRAS—skin cancer	2.62e-05	0.0018	CbGpPWpGaD
Vinblastine—SLC22A2—Transmembrane transport of small molecules—SLC12A2—skin cancer	2.62e-05	0.0018	CbGpPWpGaD
Vinblastine—JUN—EGF/EGFR Signaling Pathway—BRAF—skin cancer	2.61e-05	0.00179	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	2.58e-05	0.00177	CbGpPWpGaD
Vinblastine—JUN—TNF alpha Signaling Pathway—NRAS—skin cancer	2.58e-05	0.00177	CbGpPWpGaD
Vinblastine—JUN—ATF-2 transcription factor network—IL6—skin cancer	2.57e-05	0.00177	CbGpPWpGaD
Vinblastine—JUN—Endothelins—HRAS—skin cancer	2.55e-05	0.00175	CbGpPWpGaD
Vinblastine—JUN—MAPK Signaling Pathway—BRAF—skin cancer	2.53e-05	0.00174	CbGpPWpGaD
Vinblastine—JUN—LPA receptor mediated events—HRAS—skin cancer	2.52e-05	0.00173	CbGpPWpGaD
Vinblastine—JUN—Circadian rythm related genes—CDK4—skin cancer	2.48e-05	0.0017	CbGpPWpGaD
Vinblastine—JUN—TSH signaling pathway—HRAS—skin cancer	2.46e-05	0.00169	CbGpPWpGaD
Vinblastine—JUN—Downstream signaling in naïve CD8+ T cells—HRAS—skin cancer	2.46e-05	0.00169	CbGpPWpGaD
Vinblastine—JUN—AP-1 transcription factor network—TP53—skin cancer	2.45e-05	0.00168	CbGpPWpGaD
Vinblastine—JUN—BCR signaling pathway—HRAS—skin cancer	2.43e-05	0.00167	CbGpPWpGaD
Vinblastine—TUBA1A—Cell Cycle—CDK4—skin cancer	2.39e-05	0.00164	CbGpPWpGaD
Vinblastine—JUN—CDC42 signaling events—HRAS—skin cancer	2.34e-05	0.00161	CbGpPWpGaD
Vinblastine—JUN—ErbB1 downstream signaling—NRAS—skin cancer	2.32e-05	0.00159	CbGpPWpGaD
Vinblastine—JUN—Focal Adhesion—BRAF—skin cancer	2.29e-05	0.00158	CbGpPWpGaD
Vinblastine—JUN—DNA Damage Response (only ATM dependent)—NRAS—skin cancer	2.25e-05	0.00154	CbGpPWpGaD
Vinblastine—NR5A1—Gene Expression—ERCC2—skin cancer	2.25e-05	0.00154	CbGpPWpGaD
Vinblastine—JUN—AP-1 transcription factor network—IL6—skin cancer	2.24e-05	0.00154	CbGpPWpGaD
Vinblastine—JUN—TNF alpha Signaling Pathway—KRAS—skin cancer	2.22e-05	0.00152	CbGpPWpGaD
Vinblastine—JUN—Glucocorticoid receptor regulatory network—TP53—skin cancer	2.16e-05	0.00148	CbGpPWpGaD
Vinblastine—TUBB—Cell Cycle, Mitotic—CDK4—skin cancer	2.13e-05	0.00146	CbGpPWpGaD
Vinblastine—TUBB—Cell Cycle—TERT—skin cancer	2.13e-05	0.00146	CbGpPWpGaD
Vinblastine—JUN—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—skin cancer	2.12e-05	0.00146	CbGpPWpGaD
Vinblastine—JUN—Apoptosis—TP53—skin cancer	2.12e-05	0.00145	CbGpPWpGaD
Vinblastine—JUN—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HRAS—skin cancer	2.11e-05	0.00145	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	2.08e-05	0.00143	CbGpPWpGaD
Vinblastine—NR5A1—Developmental Biology—NRAS—skin cancer	2.05e-05	0.00141	CbGpPWpGaD
Vinblastine—TUBA1A—Cell Cycle, Mitotic—CDKN2A—skin cancer	2.04e-05	0.0014	CbGpPWpGaD
Vinblastine—TUBG1—Cell Cycle—TP53—skin cancer	2.04e-05	0.0014	CbGpPWpGaD
Vinblastine—JUN—Immune System—TLR7—skin cancer	2.02e-05	0.00138	CbGpPWpGaD
Vinblastine—JUN—Cellular Senescence—CDKN2A—skin cancer	2.02e-05	0.00138	CbGpPWpGaD
Vinblastine—JUN—PDGFR-beta signaling pathway—NRAS—skin cancer	2.02e-05	0.00138	CbGpPWpGaD
Vinblastine—JUN—ErbB1 downstream signaling—KRAS—skin cancer	1.99e-05	0.00137	CbGpPWpGaD
Vinblastine—JUN—Cellular responses to stress—CDK4—skin cancer	1.99e-05	0.00137	CbGpPWpGaD
Vinblastine—JUN—Apoptosis Modulation and Signaling—TP53—skin cancer	1.99e-05	0.00136	CbGpPWpGaD
Vinblastine—JUN—Glucocorticoid receptor regulatory network—IL6—skin cancer	1.98e-05	0.00136	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PLIN2—skin cancer	1.98e-05	0.00136	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	1.97e-05	0.00135	CbGpPWpGaD
Vinblastine—JUN—DNA Damage Response (only ATM dependent)—KRAS—skin cancer	1.94e-05	0.00133	CbGpPWpGaD
Vinblastine—JUN—MyD88 cascade initiated on plasma membrane—IL6—skin cancer	1.92e-05	0.00132	CbGpPWpGaD
Vinblastine—JUN—TCR Signaling Pathway—HRAS—skin cancer	1.92e-05	0.00132	CbGpPWpGaD
Vinblastine—TUBB—Cell Cycle—CDK4—skin cancer	1.91e-05	0.00131	CbGpPWpGaD
Vinblastine—JUN—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—skin cancer	1.9e-05	0.00131	CbGpPWpGaD
Vinblastine—JUN—TNF alpha Signaling Pathway—HRAS—skin cancer	1.88e-05	0.00129	CbGpPWpGaD
Vinblastine—JUN—MyD88 dependent cascade initiated on endosome—IL6—skin cancer	1.87e-05	0.00128	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	1.84e-05	0.00127	CbGpPWpGaD
Vinblastine—JUN—TCR Signaling Pathway—IL6—skin cancer	1.84e-05	0.00126	CbGpPWpGaD
Vinblastine—TUBA1A—Cell Cycle—CDKN2A—skin cancer	1.83e-05	0.00126	CbGpPWpGaD
Vinblastine—JUN—Wnt Signaling Pathway and Pluripotency—TP53—skin cancer	1.81e-05	0.00125	CbGpPWpGaD
Vinblastine—JUN—B Cell Receptor Signaling Pathway—HRAS—skin cancer	1.81e-05	0.00124	CbGpPWpGaD
Vinblastine—JUN—Toll Like Receptor 9 (TLR9) Cascade—IL6—skin cancer	1.8e-05	0.00124	CbGpPWpGaD
Vinblastine—JUN—TNF alpha Signaling Pathway—IL6—skin cancer	1.8e-05	0.00124	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—FOXO4—skin cancer	1.78e-05	0.00122	CbGpPWpGaD
Vinblastine—JUN—MyD88:Mal cascade initiated on plasma membrane—IL6—skin cancer	1.77e-05	0.00122	CbGpPWpGaD
Vinblastine—JUN—Senescence and Autophagy in Cancer—TP53—skin cancer	1.77e-05	0.00122	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle, Mitotic—CDK4—skin cancer	1.77e-05	0.00121	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle—TERT—skin cancer	1.76e-05	0.00121	CbGpPWpGaD
Vinblastine—NR5A1—Developmental Biology—KRAS—skin cancer	1.76e-05	0.00121	CbGpPWpGaD
Vinblastine—JUN—PDGFR-beta signaling pathway—KRAS—skin cancer	1.73e-05	0.00119	CbGpPWpGaD
Vinblastine—JUN—Signaling by NOTCH—TP53—skin cancer	1.72e-05	0.00118	CbGpPWpGaD
Vinblastine—JUN—DNA Damage Response (only ATM dependent)—TP53—skin cancer	1.72e-05	0.00118	CbGpPWpGaD
Vinblastine—JUN—MyD88-independent cascade—IL6—skin cancer	1.7e-05	0.00117	CbGpPWpGaD
Vinblastine—JUN—Senescence and Autophagy in Cancer—HRAS—skin cancer	1.69e-05	0.00116	CbGpPWpGaD
Vinblastine—JUN—ErbB1 downstream signaling—HRAS—skin cancer	1.69e-05	0.00116	CbGpPWpGaD
Vinblastine—JUN—Toll-like Receptor Signaling Pathway—IL6—skin cancer	1.66e-05	0.00114	CbGpPWpGaD
Vinblastine—JUN—DNA Damage Response (only ATM dependent)—HRAS—skin cancer	1.64e-05	0.00113	CbGpPWpGaD
Vinblastine—TUBB—Cell Cycle, Mitotic—CDKN2A—skin cancer	1.63e-05	0.00112	CbGpPWpGaD
Vinblastine—JUN—Senescence and Autophagy in Cancer—IL6—skin cancer	1.62e-05	0.00111	CbGpPWpGaD
Vinblastine—JUN—Senescence-Associated Secretory Phenotype (SASP)—IL6—skin cancer	1.62e-05	0.00111	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle, Mitotic—CDK4—skin cancer	1.62e-05	0.00111	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle—TERT—skin cancer	1.61e-05	0.00111	CbGpPWpGaD
Vinblastine—JUN—Oxidative Stress Induced Senescence—TP53—skin cancer	1.6e-05	0.0011	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PTCH2—skin cancer	1.6e-05	0.0011	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—CSPG4—skin cancer	1.59e-05	0.00109	CbGpPWpGaD
Vinblastine—JUN—MAPK Signaling Pathway—NRAS—skin cancer	1.59e-05	0.00109	CbGpPWpGaD
Vinblastine—SLC22A2—Transmission across Chemical Synapses—BRAF—skin cancer	1.58e-05	0.00109	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle—CDK4—skin cancer	1.58e-05	0.00108	CbGpPWpGaD
Vinblastine—JUN—Activated TLR4 signalling—IL6—skin cancer	1.53e-05	0.00105	CbGpPWpGaD
Vinblastine—JUN—Fc epsilon receptor (FCERI) signaling—NRAS—skin cancer	1.53e-05	0.00105	CbGpPWpGaD
Vinblastine—JUN—Cellular responses to stress—CDKN2A—skin cancer	1.52e-05	0.00105	CbGpPWpGaD
Vinblastine—NR5A1—Developmental Biology—HRAS—skin cancer	1.5e-05	0.00103	CbGpPWpGaD
Vinblastine—JUN—Integrated Breast Cancer Pathway—KRAS—skin cancer	1.49e-05	0.00102	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PLIN2—skin cancer	1.48e-05	0.00102	CbGpPWpGaD
Vinblastine—JUN—TGF-beta Signaling Pathway—TP53—skin cancer	1.48e-05	0.00101	CbGpPWpGaD
Vinblastine—JUN—PDGFR-beta signaling pathway—HRAS—skin cancer	1.47e-05	0.00101	CbGpPWpGaD
Vinblastine—TUBB—Cell Cycle—CDKN2A—skin cancer	1.46e-05	0.001	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle—CDK4—skin cancer	1.44e-05	0.000992	CbGpPWpGaD
Vinblastine—JUN—Toll Like Receptor 4 (TLR4) Cascade—IL6—skin cancer	1.44e-05	0.000988	CbGpPWpGaD
Vinblastine—NR5A1—Developmental Biology—IL6—skin cancer	1.43e-05	0.000985	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—SLC12A2—skin cancer	1.43e-05	0.000982	CbGpPWpGaD
Vinblastine—ABCC1—Disease—CSPG4—skin cancer	1.43e-05	0.000981	CbGpPWpGaD
Vinblastine—JUN—EGF/EGFR Signaling Pathway—KRAS—skin cancer	1.41e-05	0.000968	CbGpPWpGaD
Vinblastine—JUN—Direct p53 effectors—TP53—skin cancer	1.41e-05	0.000967	CbGpPWpGaD
Vinblastine—JUN—MAPK Signaling Pathway—KRAS—skin cancer	1.37e-05	0.00094	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle, Mitotic—CDKN2A—skin cancer	1.35e-05	0.000927	CbGpPWpGaD
Vinblastine—JUN—Integrated Breast Cancer Pathway—TP53—skin cancer	1.33e-05	0.00091	CbGpPWpGaD
Vinblastine—JUN—BDNF signaling pathway—HRAS—skin cancer	1.32e-05	0.000904	CbGpPWpGaD
Vinblastine—JUN—Fc epsilon receptor (FCERI) signaling—KRAS—skin cancer	1.31e-05	0.000902	CbGpPWpGaD
Vinblastine—JUN—Regulation of toll-like receptor signaling pathway—IL6—skin cancer	1.3e-05	0.00089	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PLIN2—skin cancer	1.29e-05	0.000888	CbGpPWpGaD
Vinblastine—JUN—Toll-Like Receptors Cascades—IL6—skin cancer	1.28e-05	0.00088	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	1.24e-05	0.000848	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle, Mitotic—CDKN2A—skin cancer	1.23e-05	0.000848	CbGpPWpGaD
Vinblastine—JUN—MAPK Signaling Pathway—TP53—skin cancer	1.22e-05	0.000836	CbGpPWpGaD
Vinblastine—SLC22A2—Neuronal System—BRAF—skin cancer	1.21e-05	0.000833	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—GLI2—skin cancer	1.21e-05	0.000832	CbGpPWpGaD
Vinblastine—JUN—Insulin Signaling—HRAS—skin cancer	1.21e-05	0.000831	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle—CDKN2A—skin cancer	1.21e-05	0.000829	CbGpPWpGaD
Vinblastine—JUN—EGF/EGFR Signaling Pathway—HRAS—skin cancer	1.2e-05	0.000823	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—CSPG4—skin cancer	1.2e-05	0.000822	CbGpPWpGaD
Vinblastine—JUN—Myometrial Relaxation and Contraction Pathways—IL6—skin cancer	1.19e-05	0.000816	CbGpPWpGaD
Vinblastine—JUN—SIDS Susceptibility Pathways—IL6—skin cancer	1.18e-05	0.000812	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MC1R—skin cancer	1.16e-05	0.000794	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—GLI1—skin cancer	1.14e-05	0.000782	CbGpPWpGaD
Vinblastine—JUN—Cellular Senescence—TP53—skin cancer	1.12e-05	0.00077	CbGpPWpGaD
Vinblastine—JUN—Fc epsilon receptor (FCERI) signaling—HRAS—skin cancer	1.12e-05	0.000766	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle—CDKN2A—skin cancer	1.1e-05	0.000758	CbGpPWpGaD
Vinblastine—JUN—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	1.1e-05	0.000754	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—ENO2—skin cancer	1.08e-05	0.000744	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—SUFU—skin cancer	1.08e-05	0.000742	CbGpPWpGaD
Vinblastine—JUN—Fc epsilon receptor (FCERI) signaling—IL6—skin cancer	1.07e-05	0.000734	CbGpPWpGaD
Vinblastine—JUN—Focal Adhesion—HRAS—skin cancer	1.05e-05	0.000724	CbGpPWpGaD
Vinblastine—JUN—Circadian rythm related genes—TP53—skin cancer	1.05e-05	0.000724	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—CSPG4—skin cancer	1.04e-05	0.000716	CbGpPWpGaD
Vinblastine—JUN—Immune System—FOXO4—skin cancer	1.04e-05	0.000713	CbGpPWpGaD
Vinblastine—JUN—Cellular Senescence—IL6—skin cancer	1.03e-05	0.000705	CbGpPWpGaD
Vinblastine—TUBA1A—Cell Cycle—TP53—skin cancer	1.02e-05	0.000699	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	1.01e-05	0.000696	CbGpPWpGaD
Vinblastine—ABCC1—Disease—SHH—skin cancer	9.71e-06	0.000667	CbGpPWpGaD
Vinblastine—ABCC1—Disease—ENO2—skin cancer	9.71e-06	0.000667	CbGpPWpGaD
Vinblastine—JUN—Circadian rythm related genes—IL6—skin cancer	9.65e-06	0.000663	CbGpPWpGaD
Vinblastine—JUN—Cellular responses to stress—TP53—skin cancer	8.48e-06	0.000582	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	8.47e-06	0.000582	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—SHH—skin cancer	8.24e-06	0.000566	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—RASA1—skin cancer	8.19e-06	0.000562	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—ENO2—skin cancer	8.13e-06	0.000559	CbGpPWpGaD
Vinblastine—TUBB—Cell Cycle—TP53—skin cancer	8.11e-06	0.000557	CbGpPWpGaD
Vinblastine—ABCC1—Disease—FOXO4—skin cancer	7.92e-06	0.000544	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—SMO—skin cancer	7.81e-06	0.000536	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PTCH1—skin cancer	7.81e-06	0.000536	CbGpPWpGaD
Vinblastine—JUN—Cellular responses to stress—IL6—skin cancer	7.76e-06	0.000533	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PTGER4—skin cancer	7.6e-06	0.000522	CbGpPWpGaD
Vinblastine—SLC22A2—Transmission across Chemical Synapses—HRAS—skin cancer	7.28e-06	0.0005	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	7.25e-06	0.000498	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—ENO2—skin cancer	7.08e-06	0.000486	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PLIN2—skin cancer	7.06e-06	0.000485	CbGpPWpGaD
Vinblastine—TUBB4A—Cell Cycle—TP53—skin cancer	6.72e-06	0.000461	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—FOXO4—skin cancer	6.71e-06	0.000461	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PLIN2—skin cancer	6.66e-06	0.000457	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	6.36e-06	0.000437	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—ERCC2—skin cancer	6.29e-06	0.000432	CbGpPWpGaD
Vinblastine—TUBB4B—Cell Cycle—TP53—skin cancer	6.14e-06	0.000422	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—NRAS—skin cancer	5.93e-06	0.000407	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CSPG4—skin cancer	5.69e-06	0.000391	CbGpPWpGaD
Vinblastine—ABCC1—Disease—ERCC2—skin cancer	5.64e-06	0.000387	CbGpPWpGaD
Vinblastine—SLC22A2—Neuronal System—HRAS—skin cancer	5.58e-06	0.000383	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CSPG4—skin cancer	5.36e-06	0.000368	CbGpPWpGaD
Vinblastine—ABCC1—Disease—TERT—skin cancer	5.29e-06	0.000363	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—KRAS—skin cancer	5.1e-06	0.00035	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	4.85e-06	0.000333	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—ERCC2—skin cancer	4.72e-06	0.000324	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TERT—skin cancer	4.48e-06	0.000308	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PLIN2—skin cancer	4.35e-06	0.000299	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—HRAS—skin cancer	4.34e-06	0.000298	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	4.31e-06	0.000296	CbGpPWpGaD
Vinblastine—ABCC1—Disease—BRAF—skin cancer	4.19e-06	0.000288	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—IL6—skin cancer	4.15e-06	0.000285	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—ERCC2—skin cancer	4.11e-06	0.000283	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ENO2—skin cancer	3.87e-06	0.000266	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PTGS2—skin cancer	3.77e-06	0.000259	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ENO2—skin cancer	3.65e-06	0.00025	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—BRAF—skin cancer	3.55e-06	0.000244	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CSPG4—skin cancer	3.51e-06	0.000241	CbGpPWpGaD
Vinblastine—JUN—Immune System—NRAS—skin cancer	3.45e-06	0.000237	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PTGS2—skin cancer	3.38e-06	0.000232	CbGpPWpGaD
Vinblastine—JUN—Immune System—KRAS—skin cancer	2.97e-06	0.000204	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PTGS2—skin cancer	2.83e-06	0.000195	CbGpPWpGaD
Vinblastine—ABCC1—Disease—NRAS—skin cancer	2.63e-06	0.000181	CbGpPWpGaD
Vinblastine—JUN—Immune System—HRAS—skin cancer	2.53e-06	0.000173	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PTGS2—skin cancer	2.47e-06	0.000169	CbGpPWpGaD
Vinblastine—JUN—Immune System—IL6—skin cancer	2.42e-06	0.000166	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ENO2—skin cancer	2.38e-06	0.000164	CbGpPWpGaD
Vinblastine—ABCC1—Disease—KRAS—skin cancer	2.27e-06	0.000156	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ERCC2—skin cancer	2.25e-06	0.000154	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—NRAS—skin cancer	2.23e-06	0.000153	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ERCC2—skin cancer	2.12e-06	0.000145	CbGpPWpGaD
Vinblastine—ABCC1—Disease—HRAS—skin cancer	1.93e-06	0.000132	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—KRAS—skin cancer	1.92e-06	0.000132	CbGpPWpGaD
Vinblastine—ABCC1—Disease—IL6—skin cancer	1.84e-06	0.000127	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TP53—skin cancer	1.71e-06	0.000117	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—HRAS—skin cancer	1.63e-06	0.000112	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IL6—skin cancer	1.56e-06	0.000107	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ERCC2—skin cancer	1.38e-06	9.51e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PTGS2—skin cancer	1.35e-06	9.26e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PTGS2—skin cancer	1.27e-06	8.72e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PTGS2—skin cancer	8.3e-07	5.7e-05	CbGpPWpGaD
